Unknown

Dataset Information

0

Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives.


ABSTRACT: Evidence has emerged implicating epigenetic alterations in inflammatory breast cancer (IBC) origin and progression. IBC is a rare and rapidly progressing disease, considered the most aggressive type of breast cancer (BC). At clinical presentation, IBC is characterized by diffuse erythema, skin ridging, dermal lymphatic invasion, and peau d'orange aspect. The widespread distribution of the tumor as emboli throughout the breast and intra- and intertumor heterogeneity is associated with its poor prognosis. In this review, we highlighted studies documenting the essential roles of epigenetic mechanisms in remodeling chromatin and modulating gene expression during mammary gland differentiation and the development of IBC. Compiling evidence has emerged implicating epigenetic changes as a common denominator linking the main risk factors (socioeconomic status, environmental exposure to endocrine disruptors, racial disparities, and obesity) with IBC development. DNA methylation changes and their impact on the diagnosis, prognosis, and treatment of IBC are also described. Recent studies are focusing on the use of histone deacetylase inhibitors as promising epigenetic drugs for treating IBC. All efforts must be undertaken to unravel the epigenetic marks that drive this disease and how this knowledge could impact strategies to reduce the risk of IBC development and progression.

SUBMITTER: Faldoni FLC 

PROVIDER: S-EPMC7291154 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives.

Faldoni Flavia Lima Costa FLC   Rainho Cláudia Aparecida CA   Rogatto Silvia Regina SR  

Cells 20200508 5


Evidence has emerged implicating epigenetic alterations in inflammatory breast cancer (IBC) origin and progression. IBC is a rare and rapidly progressing disease, considered the most aggressive type of breast cancer (BC). At clinical presentation, IBC is characterized by diffuse erythema, skin ridging, dermal lymphatic invasion, and peau d'orange aspect. The widespread distribution of the tumor as emboli throughout the breast and intra- and intertumor heterogeneity is associated with its poor pr  ...[more]

Similar Datasets

| S-EPMC7603197 | biostudies-literature
| S-EPMC3515719 | biostudies-literature
| S-EPMC7761669 | biostudies-literature
| S-EPMC2819039 | biostudies-other
| S-EPMC5527941 | biostudies-other
| S-EPMC10596062 | biostudies-literature
| S-EPMC9320771 | biostudies-literature
| S-EPMC6799843 | biostudies-literature
| S-EPMC7228650 | biostudies-literature
| S-EPMC4127614 | biostudies-literature